- RGEN has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $21.5 million.
- RGEN has traded 11,677 shares today.
- RGEN is trading at a new lifetime high.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in RGEN with the Ticky from Trade-Ideas. See the FREE profile for RGEN NOW at Trade-Ideas More details on RGEN: Repligen Corporation, a life sciences company, develops, manufactures, and markets consumable bioprocessing products for use in the production of monoclonal antibodies and other biologic drugs. RGEN has a PE ratio of 19. Currently there are 2 analysts that rate Repligen a buy, no analysts rate it a sell, and none rate it a hold. The average volume for Repligen has been 433,700 shares per day over the past 30 days. Repligen has a market cap of $1.3 billion and is part of the health care sector and drugs industry. The stock has a beta of 0.89 and a short float of 12.1% with 6.64 days to cover. Shares are up 101.4% year-to-date as of the close of trading on Wednesday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.